Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia.

DOI Web Site PubMed 1 Citations 39 References

Bibliographic Information

Other Title
  • 実験的アノキシアおよび脳虚血に対するカルシウムきっ抗薬塩酸エホニジピンの効果
  • ジッケンテキ アノキシア オヨビ ノウ キョケツ ニ タイスル カルシウム キ

Search this article

Abstract

The anti-ischemic and anti-anoxic effects of efonidipine, a dihydropyridine calcium antagonist, were studied in several models for cerebral ischemia and anoxia in mice and rats, and the effects were compared with those of nicardipine and flunarizine. Both efonidipine and flunarizine showed protective effects in the models of KCN-induced anoxia and complete ischemia induced by decapitation in mice 6 hr after the treatment, while nicardipine did not show such a longlasting effect. Efonidipine (1 mg/kg, i.p.), but not nicardipine and flunarizine, prolonged the tolerance times in the asphyxic anoxia model. In mice, efonidipine (4 mg/kg, i.p.) significantly reduced the cumulative mortality rate after bilateral carotid artery ligation. The survival rates at 20 hr after bilateral carotid artery ligation were 33% in the group treated with efonidipine, significantly higher than that in the control group, 0%. On the other hand, the treatment with nicardipine or flunarizine did not increase the rates at 20 hr after the ligation. Moreover, efonidipine attenuated the disturbance of cerebral energy metabolism induced by decapitation in rats. These effects of efonidipine observed in this study were on the whole superior to those of the reference drugs, strongly suggesting the improving effect of efonidipine on cerebral ischemia and anoxia.

Journal

Citations (1)*help

See more

References(39)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top